Article Details

InflaRX set to file for MAA for vilobelimab - European Biotechnology

Retrieved on: 2022-07-27 05:59:59

Tags for this article:

Click the tags to see associated articles and topics

InflaRX set to file for MAA for vilobelimab - European Biotechnology. View article details on hiswai:

Excerpt

InflaRx plans to apply for Emergency Use Authorization from the US FDA in Q3/2022 for vilobelimab, the company's treatment for critically ill ...

Article found on: european-biotechnology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up